A Phase 2b, Randomized, Double-Blind Vehicle Controlled, Dose Escalation Study Evaluating Clascoterone 0.1%, 0.5%, and 1% Topical Cream in Subjects with Facial Acne
Mazzetti, A.; Moro, L.; Gerloni, M.; Cartwright, M.
Journal of Drugs in Dermatology Jdd 18(6): 570
2019
ISSN/ISBN: 1545-9616 PMID: 31251550 Document Number: 699465
Androgens play a key role in acne pathogenesis in both males and females. Clascoterone (CB-03-01, Cortexolone 17α propionate) cream is a topical anti-androgen under investigation for the treatment of acne. The results from a phase 2b dose escalating study are discussed.
Document emailed within 1 workday
Related Documents
Parish, L.C.; Parish, J.L.; Routh, H.B.; Avakian, E.; Olayinka, B.; Pappert, E.J.; Plaum, S.; Fleischer, A.B.; Hardas, B. 2011: A double-blind, randomized, vehicle-controlled study evaluating the efficacy and safety of naftifine 2% cream in tinea cruris Journal of Drugs in Dermatology: Jdd 10(10): 1142-1147Eichenfield, L.F.; Alió Sáenz, A.B. 2011: Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study Journal of Drugs in Dermatology: Jdd 10(12): 1382-1396
Herzog, J.L.; Solomon, J.A.; Draelos, Z.; Fleischer, A.; Stough, D.; Wolf, D.I.; Abramovits, W.; Werschler, W.; Green, E.; Duffy, M.; Rothaul, A.; Tansley, R. 2011: A randomized, double-blind, vehicle-controlled crossover study to determine the anti-pruritic efficacy, safety and local dermal tolerability of a topical formulation (srd174 cream) of the long-acting opiod antagonist nalmefene in subjects with atopic dermatitis Journal of Drugs in Dermatology: Jdd 10(8): 853-860
Shalita, A.; Miller, B.; Menter, A.; Abramovits, W.; Loven, K.; Kakita, L. 2005: Tazarotene cream versus adapalene cream in the treatment of facial acne vulgaris: a multicenter, double-blind, randomized, parallel-group study Journal of Drugs in Dermatology: Jdd 4(2): 153-158
Parish, L.C.; Parish, J.L.; Routh, H.B.; Fleischer, A.B.; Avakian, E.V.; Plaum, S.; Hardas, B. 2011: A randomized, double-blind, vehicle-controlled efficacy and safety study of naftifine 2% cream in the treatment of tinea pedis Journal of Drugs in Dermatology: Jdd 10(11): 1282-1288
Fowler, J.; Jackson, M.; Moore, A.; Jarratt, M.; Jones, T.; Meadows, K.; Steinhoff, M.; Rudisill, D.; Leoni, M. 2013: Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies Journal of Drugs in Dermatology: Jdd 12(6): 650-656
Feldman, S.R.; Werner, C.P.; Alió Saenz, A.B. 2013: The efficacy and tolerability of tazarotene foam, 0.1%, in the treatment of acne vulgaris in 2 multicenter, randomized, vehicle-controlled, double-blind studies Journal of Drugs in Dermatology: Jdd 12(4): 438-446
Webster, G.F.; Leyden, J.J.; Gross, J.A. 2014: Results of a Phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-Lidose in patients with severe recalcitrant nodular acne Journal of Drugs in Dermatology: Jdd 13(6): 665-670
Gold, L.S.; Papp, K.; Lynde, C.; Lain, E.; Gooderham, M.; Johnson, S.; Kerrouche, N. 2017: Treatment of Rosacea with Concomitant use of Topical Ivermectin 1% Cream and Brimonidine 0.33% Gel: a Randomized, Vehicle-controlled Study Journal of Drugs in Dermatology: Jdd 16(9): 909-916
Stein-Gold, L.; Kircik, L.; Draelos, Z.D.; Werschler, P.; DuBois, J.; Lain, E.; Baumann, L.; Goldberg, D.; Kaufman, J.; Tanghetti, E.; Ahluwalia, G.; Alvandi, N.; Weng, E.; Berk, D. 2018: Topical Oxymetazoline Cream 1.0% for Persistent Facial Erythema Associated with Rosacea: Pooled Analysis of the two Phase 3, 29-Day, Randomized, Controlled REVEAL Trials Journal of Drugs in Dermatology: Jdd 17(11): 1201-1208
Menter, A.; Gold, L.S.; Bukhalo, M.; Grekin, S.; Kempers, S.; Boyce, B.M.; Ganslandt, C.; Villumsen, J.; Lebwohl, M. 2013: Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trial Journal of Drugs in Dermatology: Jdd 12(1): 92-98
Murray, J.; Potts, A. 2014: The phototoxic and photoallergy potential of clindamycin phosphate 1.2%/ tretinoin 0.025% gel for facial acne: results of two single-center, evaluator-blinded, randomized, vehicle-controlled phase 1 studies in healthy volunteers Journal of Drugs in Dermatology: Jdd 13(1): 16-22
Widgerow, A.D..; Moradi, A.; Poehler, J. 2019: A Double-Blind Randomized Controlled Trial Evaluating the Efficacy and Tolerability of a Topical Body Treatment in Combination with Cryolipolysis Procedures Journal of Drugs in Dermatology: Jdd 18(4): 342-348
Plewig, G.; Cunliffe, W.J.; Binder, N.; Höschen, K. 2009: Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase IIi trial Contraception 80(1): 25-33
Jorizzo, J.; Weiss, J.; Vamvakias, G. 2006: One-week treatment with 0.5% fluorouracil cream prior to cryosurgery in patients with actinic keratoses: a double-blind, vehicle-controlled, long-term study Journal of Drugs in Dermatology: Jdd 5(2): 133-139
Scher, R.K.; Stiller, M.; Zhu, Y.I. 2001: Tazarotene 0.1% gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled study Cutis 68(5): 355-358
Tucker-Samaras, S.; Zedayko, T.; Cole, C.; Miller, D.; Wallo, W.; Leyden, J.J. 2009: A stabilized 0.1% retinol facial moisturizer improves the appearance of photodamaged skin in an eight-week, double-blind, vehicle-controlled study Journal of Drugs in Dermatology: Jdd 8(10): 932-936
Diehl, C.; Ferrari, A. 2013: Efficacy of topical 4% Quassia amara gel in facial seborrheic dermatitis:a randomized, double-blind, comparative study Journal of Drugs in Dermatology: Jdd 12(3): 312-315
Trnavský, K.; Fischer, M.; Vögtle-Junkert, U.; Schreyger, F. 2004: Efficacy and safety of 5% ibuprofen cream treatment in knee osteoarthritis. Results of a randomized, double-blind, placebo-controlled study Journal of Rheumatology 31(3): 565-572
Webster, G.F.; Guenther, L.; Poulin, Y.P.; Solomon, B.A.; Loven, K.; Lee, J. 2002: A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris Cutis 69(2 Suppl): 4-11